BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18799467)

  • 1. Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo.
    Lund IK; Jögi A; Rønø B; Rasch MG; Lund LR; Almholt K; Gårdsvoll H; Behrendt N; Rømer J; Høyer-Hansen G
    J Biol Chem; 2008 Nov; 283(47):32506-15. PubMed ID: 18799467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
    Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
    Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.
    Jögi A; Rønø B; Lund IK; Nielsen BS; Ploug M; Høyer-Hansen G; Rømer J; Lund LR
    PLoS One; 2010 Sep; 5(9):e12746. PubMed ID: 20856796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
    EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies.
    Botkjaer KA; Fogh S; Bekes EC; Chen Z; Blouse GE; Jensen JM; Mortensen KK; Huang M; Deryugina E; Quigley JP; Declerck PJ; Andreasen PA
    Biochem J; 2011 Aug; 438(1):39-51. PubMed ID: 21635223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
    List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
    Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
    Rasch MG; Pass J; Illemann M; Høyer-Hansen G; Lund IK
    J Immunol Methods; 2008 Nov; 339(1):55-65. PubMed ID: 18761343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase mediates fibrinolysis in the pulmonary microvasculature.
    Bdeir K; Murciano JC; Tomaszewski J; Koniaris L; Martinez J; Cines DB; Muzykantov VR; Higazi AA
    Blood; 2000 Sep; 96(5):1820-6. PubMed ID: 10961882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo.
    Lund IK; Rasch MG; Ingvarsen S; Pass J; Madsen DH; Engelholm LH; Behrendt N; Høyer-Hansen G
    Front Pharmacol; 2012; 3():122. PubMed ID: 22754528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation.
    Ellis V; Danø K
    J Biol Chem; 1993 Mar; 268(7):4806-13. PubMed ID: 8444857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.
    Lluís F; Roma J; Suelves M; Parra M; Aniorte G; Gallardo E; Illa I; Rodríguez L; Hughes SM; Carmeliet P; Roig M; Muñoz-Cánoves P
    Blood; 2001 Mar; 97(6):1703-11. PubMed ID: 11238111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
    Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
    J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
    J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A; Kramer MD; Schirrmacher V; Brunner G
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
    Chintala SK
    Exp Eye Res; 2016 Feb; 143():17-27. PubMed ID: 26474495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N; List K; Andreasen PA; Danø K
    Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung.
    Hattori N; Sisson TH; Xu Y; Desai TJ; Simon RH
    Am J Physiol; 1999 Sep; 277(3):L573-9. PubMed ID: 10484465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of the plasminogen activation system promote engraftment of porous polyethylene biomaterial via common and distinct effects.
    Reichel CA; Hessenauer ME; Pflieger K; Rehberg M; Kanse SM; Zahler S; Krombach F; Berghaus A; Strieth S
    PLoS One; 2015; 10(2):e0116883. PubMed ID: 25658820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.